Troubled Intuitive Surgical manages to blow away Wall Street's expectations, even as Q2 profits drop 35% year-over-year.
California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street's expectations by a mile.
Abbott Labs reports a strong 2nd quarter driven in large part by diagnostics, but the medical device segment took a hit in U.S. sales, leading to a pretty flat quarter.
Illinois-based Abbott (NYSE:ABT) released a 2nd-quarter earnings report showing some strong momentum, but the healthcare giant's medical device sector didn't fare so well.
Industry giant GE posts another lackluster quarter for its healthcare business with flat sales and profits for Q2 and low expectations for the rest of the year.
GE Healthcare (NYSE:GE) isn't terribly optimistic about its prospects for the rest of this year as its 2nd-quarter earnings report again shows softness in the U.S. dragging down total healthcare activity.
Stryker Corp. reports 2nd-quarter earnings that meet Wall Street's expectations, despite flat profit growth on 7% sales growth.
Stryker (NYSE:SYK) said today that its 2nd-quarter earnings met expectations on Wall Street, despite flat profit growth, on 7% sales growth.
Baxter reports 2nd-quarter sales growth of more than 16% and beats earnings expectations, but narrows its full-year earnings guidance.
Johnson & Johnson's pharmaceuticals division helps buoy the healthcare giant to another beat & raise quarter, but its medical device division again fails to meet expectations.
Biomet puts black ink back in the ledger for its fiscal 4th quarter and 2014, reporting double-digit adjusted profit increases for both periods.
Biomet said yesterday that it put black ink back into its books for the fiscal 4th quarter and 2014, with adjusted profits rising by double digits.